Brief: Lavipharm Signs An Asset Purchase Agreement With Sanofi For The Acquisition Of Flagyl For The Greek Market

Lavipharm SA

11/12/2023 08:24

Dec 11 (Reuters) - Lavipharm SA  LPHr.AT :
    * ENTERS INTO AN ASSET PURCHASE AGREEMENT WITH SANOFI FOR
THE
ACQUISITION OF THE PHARMACEUTICAL PRODUCT FLAGYL FOR THE GREEK
MARKET
    * COMMERCIALIZATION OF THE PRODUCT BY LAVIPHARM IS EXPECTED
TO
TAKE PLACE DURING Q2 2024
    * THE TRANSACTION WILL BE FINANCED BY THE COMPANY'S OWN
FUNDS


Further company coverage:  LPHr.AT 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))